SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11206598
Source:
http://linkedlifedata.com/resource/pubmed/id/11206598
Search
Subject
(
51
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0016365
,
umls-concept:C0087111
,
umls-concept:C0332174
,
umls-concept:C0524527
,
umls-concept:C1269683
,
umls-concept:C1321605
pubmed:issue
12
pubmed:dateCreated
2001-2-5
pubmed:abstractText
A new formulation of enteric-coated fluoxetine given once weekly could be a useful option for the long-term treatment of depression, but compliance to once-weekly fluoxetine treatment has not been assessed.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7801243
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Fluoxetine
,
http://linkedlifedata.com/resource/pubmed/chemical/Tablets, Enteric-Coated
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0160-6689
pubmed:author
pubmed-author:ClaxtonAA
,
pubmed-author:ParryMM
,
pubmed-author:RobinsonJ MJM
,
pubmed-author:SchmidtM EME
,
pubmed-author:de KlerkEE
pubmed:issnType
Print
pubmed:volume
61
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
928-32
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11206598-Adult
,
pubmed-meshheading:11206598-Depressive Disorder
,
pubmed-meshheading:11206598-Drug Administration Schedule
,
pubmed-meshheading:11206598-Drug Packaging
,
pubmed-meshheading:11206598-Female
,
pubmed-meshheading:11206598-Fluoxetine
,
pubmed-meshheading:11206598-Humans
,
pubmed-meshheading:11206598-Male
,
pubmed-meshheading:11206598-Middle Aged
,
pubmed-meshheading:11206598-Patient Compliance
,
pubmed-meshheading:11206598-Psychiatric Status Rating Scales
,
pubmed-meshheading:11206598-Recurrence
,
pubmed-meshheading:11206598-Tablets, Enteric-Coated
,
pubmed-meshheading:11206598-Treatment Outcome
pubmed:year
2000
pubmed:articleTitle
Patient compliance to a new enteric-coated weekly formulation of fluoxetine during continuation treatment of major depressive disorder.
pubmed:affiliation
Lilly Research Laboratories, Indianapolis, Ind 46285, USA. Ami.Claxton@lilly.com
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study